Ui-Yeol Choe
Chief Executive Officer bei BODITECH MED INC.
Vermögen: 53 Mio $ am 31.03.2024
Profil
Ui-Yeol Choe is currently the Chief Executive Officer & Director at Boditech Med, Inc. and Vice Chairman at Korea Biochip Society.
Previously, he worked as the Chief Executive Officer at Boditech Med, Inc. Choe holds a doctorate degree from Tennessee State University and Yale University.
He also has undergraduate and graduate degrees from Seoul National University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
BODITECH MED, INC.
21,18% | 30.09.2022 | 4 974 579 ( 21,18% ) | 53 Mio $ | 31.03.2024 |
Aktive Positionen von Ui-Yeol Choe
| Unternehmen | Position | Beginn |
|---|---|---|
| BODITECH MED INC. | Chief Executive Officer | 01.01.1999 |
| Korea Biochip Society | Director/Board Member | 01.01.2015 |
Ehemalige bekannte Positionen von Ui-Yeol Choe
| Unternehmen | Position | Ende |
|---|---|---|
Boditech Med, Inc. /Old/
 Boditech Med, Inc. /Old/ Medical SpecialtiesHealth Technology Boditech Med, Inc. is a holding company, which provides in-vitro diagnostics analyzers and reagents. Its products include biochemical markers, immunofluorescence assay system, and hemoglobin analyzers. The company was founded on November 13, 1998 and is headquartered in Chuncheon, South Korea. | Chief Executive Officer | - |
Ausbildung von Ui-Yeol Choe
| Tennessee State University | Doctorate Degree |
| Yale University | Doctorate Degree |
| Seoul National University | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
Boditech Med, Inc. /Old/
Boditech Med, Inc. /Old/ Medical SpecialtiesHealth Technology Boditech Med, Inc. is a holding company, which provides in-vitro diagnostics analyzers and reagents. Its products include biochemical markers, immunofluorescence assay system, and hemoglobin analyzers. The company was founded on November 13, 1998 and is headquartered in Chuncheon, South Korea. | Health Technology |
| Korea Biochip Society | |
| Boditech Med, Inc. |
